Summary of updates on ovarian cancer indications for PARP inhibitors

As the weather gradually turns cooler, do tumors also respond to temperature changes?

The 2023 FIGO staging of endometrial cancer includes molecular classification

Moboxetinib and sotoraxib have suffered setbacks one after another. What are the primary endpoints and secondary endpoints of clinical trials of anti-tumor drugs?